S-Space

Browse

Subject

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 22 of 22

Issue Date	Title / Author(s) / Citation	File
1997-03	Mutation of ras oncogene in gastric adenocarcinoma: Association with histological phenotype Kim, TY; Bang, YJ; Kim, WS; Kang, SH; Lee, KU; Choe, KJ; Kim, NK Anticancer Research, Vol.17 No.2B, pp.1335-1339
2004-09	Cyclooxygenase-2 and p53 expressions in endometrial cancer Jeon, Yong-Tark; Kang, Sokbom; Kang, 4 Dae-Hee; Yoo, Keun-Young; Park, In-Ae; Bang, Yung-Jue; Kim, Jae Weon; Park, Noh-Hyun; Kang, Soon-Beom; Lee, Hyo-Pyo; Song, Yong-Sang Cancer Epidemiology Biomarkers and Prevention, Vol.13 No.9, pp.1538-1542
2005-03	Cyclooxygenase-2 inhibits novel ginseng metabolite-mediated apoptosis Yim, Hyung Woo; Jong, Hyun-Soon; Kim, Tai Young; Choi, Hyun Ho; Kim, Sang Gyun; Song, Sang Hyun; Kim, Juyong; Ko, Seong-Gyu; Lee, Jung Weon; Kim, Tae-You; Bang, Yung-Jue Cancer Research, Vol.65 No.5, pp.1952-1960	DOI
2008-02	Metastasis-associated protein S100A4 and p53 predict relapse in curatively resected stage III and IV (M0) gastric cancer Kim, Yu Jung; Kim, Min A.; Im, Seock-Ah; Kim, Tae Min; Kim, Dong-Wan; Yang, Han-Kwang; Heo, Dae Seog; Lee, Kuhn-Uk; Choe, Kuk Jin; Kim, Noe Kyeong; Kim, Tae-You; Kim, Woo Ho; Bang, Yung-Jue Cancer Investigation, Vol.26 No.2, pp.152-158	DOI
2010-02	Metaplastic Breast Carcinoma: Clinicopathologic Features and Prognostic Value of Triple Negativity Lim, Kyu-Hyoung; Oh, Do-Youn; Chie, Eui Kyu; Han, Wonshik; Im, Seock-Ah; Kim, Tae-You; Park, In Ae; Noh, Dong-Young; Ha, Sung Whan; Bang, Yung-Jue Japanese Journal of Clinical Oncology, Vol.40 No.2, pp.112-118	DOI
2010-02	CADPE Suppresses Cyclin D1 Expression in Hepatocellular Carcinoma by Blocking IL-6-induced STAT3 Activation Won, Cheolhee; Lee, Chang Seok; Lee, Jin-Ku; Kim, Tack-Joong; Lee, Kwang-Ho; Yang, Young Mok; Kim, Yong-Nyun; Ye, Sang-Kyu; Chung, Myung-Hee Anticancer Research, Vol.30 No.2, pp.481-488
2010-06	P-cadherin expression in gastric carcinoma: its regulation mechanism and prognostic significance Kim, Min A.; Jung, Eun Ji; Lee, Hye Seung; Lee, Hee Eun; Yang, Han-Kwang; Oh, Do-Youn; Bang, Yung-Jue; Kim, Woo Ho Human Pathology, Vol.41 No.6, pp.877-885	DOI
2010-06	DNA methyltransferase 3-like affects promoter methylation of thymine DNA glycosylase independently of DNMT1 and DNMT3B in cancer cells Kim, Heesun; Park, Jinah; Jung, Yeonjoo; Song, Sang-Hyun; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Kim, Tae-You International Journal of Oncology, Vol.36 No.6, pp.1563-1572	DOI
2011-06	Clinicopathologic characteristics of patients with stage III/IV (M 0) advanced gastric cancer, according to HER2 status assessed by immunohistochemistry and fluorescence in situ hybridization Im, Seock-Ah; Kim, Jin Won; Kim, Jin-Soo; Kim, Min A.; Jordan, Bruce; Pickl, Marlene; Han, Sae-Won; Oh, Do-Youn; Lee, Hyuk Joon; Kim, Tae-You; Kim, Woo Ho; Yang, Han-Kwang; Bang, Yung-Jue Diagnostic Molecular Pathology, Vol.20 No.2, pp.94-100	DOI
2012-02	Evaluation of the Antitumor Effects and Mechanisms of PF00299804, a Pan-HER Inhibitor, Alone or in Combination with Chemotherapy or Targeted Agents in Gastric Cancer Nam, Hyun-Jin; Ching, Keith A.; Kan, Julie; Kim, Hwang-Phill; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Christensen, James G.; Oh, Do-Youn; Bang, Yung-Jue Molecular Cancer Therapeutics, Vol.11 No.2, pp.439-451	DOI
2012-06	A phase II trial of erlotinib in combination with gemcitabine and capecitabine in previously untreated metastatic/recurrent pancreatic cancer: combined analysis with translational research Oh, Do-Youn; Lee, Keun Wook; Lee, Kyung-Hee; Sohn, Chang-Hak; Park, Young Suk; Zang, Dae Young; Ryoo, Hun-Mo; Song, Hong-Suk; Kim, Jin-Soo; Kang, Hye-Jin; Kim, Bong-Seog; Bang, Yung-Jue Investigational New Drugs, Vol.30 No.3, pp.1164-1174	DOI
2012-07	MET in gastric carcinomas: comparison between protein expression and gene copy number and impact on clinical outcome Lee, H. E.; Kim, M. A.; Lee, H. S.; Jung, E-J; Yang, H-K; Lee, B. L.; Bang, Y-J; Kim, W. H. British Journal of Cancer, Vol.107 No.2, pp.325-333	DOI
2016-05	Expression of breast cancer stem cell markers as predictors of prognosis and response to trastuzumab in HER2-positive breast cancer Seo, An Na; Lee, Hee Jin; Kim, Eun Joo; Jang, Min Hye; Kim, Yu Jung; Kim, Jee Hyun; Kim, Sung-Won; Ryu, Han Suk; Park, In Ae; Im, Seock-Ah; Gong, Gyungyub; Jung, Kyung Hae; Kim, Hee Jeong; Park, So Yeon British Journal of Cancer, Vol.114 No.10, pp.1109-1116	DOI
2016-06	Is c-Met oncoprotein expression an adverse prognosticator in extrahepatic bile duct cancer treated with curative resection followed by adjuvant chemoradiotherapy? Park, H. J.; Kim, K.; Paik, J. H.; Chie, E. K.; Kim, S.; Jang, J. -Y.; Kim, S. W.; Han, S. -W.; Oh, D. -Y.; Im, S. -A.; Kim, T. -Y.; Bang, Y. -J.; Ha, S. W. Clinical and Translational Oncology, Vol.18 No.6, pp.625-631	DOI
2017-09	Human Epidermal Growth Factor Receptor 2 Expression in Unresectable Gastric Cancers: Relationship with CT Characteristics Lee, Jeong Sub; Kim, Se Hyung; Im, Seock-Ah; Kim, Min A.; Han, Joon Koo Korean Journal of Radiology, Vol.18 No.5, pp.809-820	DOI
2017-09	Clinicopathologic implications of the miR-197/PD-L1 axis in oral squamous cell carcinoma Ahn, Hyein; Yang, Jeong Mi; Kim, Hyojin; Chung, Jin-Haeng; Ahn, Soon-Hyun; Jeong, Woo-Jin; Paik, Jin Ho Oncotarget, Vol.8 No.39, pp.66178-66194	DOI
2017-11	Diagnostic performance enhancement of pancreatic cancer using proteomic multimarker panel Park, Jiyoung; Choi, Yonghwan; Namkung, Junghyun; Yi, Sung Gon; Kim, Hyunsoo; Yu, Jiyoung; Kim, Yongkang; Kwon, Min-Seok; Kwon, Wooil; Oh, Do-Youn; Kim, Sun-Whe; Jeong, Seung-Yong; Han, Wonshik; Lee, Kyu Eun; Heo, Jin Seok; Park, Joon Oh; Park, Joo Kyung; Kim, Song Cheol; Kang, Chang Moo; Lee, Woo Jin; Lee, Seungyeoun; Han, Sangjo; Park, Taesung; Jang, Jin-Young; Kim, Youngsoo Oncotarget, Vol.8 No.54, pp.93117-93130	DOI
2017-12	Anti-tumor effects of NVP-BKM120 alone or in combination with MEK162 in biliary tract cancer Jin, Ling; Jin, Mei-hua; Nam, Ah-Rong; Park, Ji-Eun; Bang, Ju-Hee; Oh, Do Yeun; Bang, Yung Jue Cancer Letters, Vol.411, pp.162-170	DOI
2018-11	Clinicopathologic implication of PD-L1 and phosphorylated STAT3 expression in diffuse large B cell lymphoma Kwon, Hyun Jung; Yang, Jeong Mi; Lee, Jeong-Ok; Lee, Jong Seok; Paik, Jin Ho Journal of Translational Medicine, Vol.16 No.1, p. 320	DOI
2019-01	Epidermal growth factor receptor gene amplification predicts worse outcome in patients with surgically resected nonadenocarcinoma lung cancer Chang, Hyun; Yang, Yaewon; Lee, Jong-Seok; Jheon, Sang-Hoon; Kim, Yu Jung; Chung, Jin-Haeng Clinical Lung Cancer, Vol.20 No.1, pp.7-12.e1	DOI
2020-02	Altered expression of fucosylation pathway genes is associated with poor prognosis and tumor metastasis in non-small cell lung cancer Park, Soonbum; Lim, Jin-Muk; Chun, Jung Nyeo; Lee, Sanghoon; Kim, Tae Min; Kim, Dong-Wan; Kim, Sang-Yeob; Bae, Dong-Jun; Bae, Sang-Mun; So, Insuk; Kim, Hong-Gee; Choi, Ji-Yeob; Jeon, Ju-Hong International Journal of Oncology, Vol.56 No.2, pp.559-567	DOI
2020-07	Phase I Escalation and Expansion Study of Bemarituzumab (FPA144) in Patients With Advanced Solid Tumors and FGFR2b-Selected Gastroesophageal Adenocarcinoma Catenacci, Daniel V. T.; Rasco, Drew; Lee, Jeeyun; Rha, Sun Young; Lee, Keun-Wook; Bang, Yung Jue; Bendell, Johanna; Enzinger, Peter; Marina, Neyssa; Xiang, Hong; Deng, Wei; Powers, Janine; Wainberg, Zev A. Journal of Clinical Oncology, Vol.38 No.21, pp.2418-2426	DOI